scholarly journals What should I tell my patient? Disclosure in anaesthesiology: difficulties, requirements, guidelines and suggestions

2018 ◽  
Vol 24 (1) ◽  
pp. 1-8 ◽  
Author(s):  
Malcolm de Roubaix
Keyword(s):  
Patient Disclosure

An Initial Investigation of Suicide Attempt Disclosures Among US Veterans

Crisis ◽  
2020 ◽  
pp. 1-7
Author(s):  
Brooke A. Ammerman ◽  
Sarah P. Carter ◽  
Heather M. Gebhardt ◽  
Jonathan Buchholz ◽  
Mark A. Reger
Keyword(s):  
Suicide Attempt ◽  
Mental Health Professionals ◽  
Help Seeking ◽  
Psychiatric Treatment ◽  
Small Sample Size ◽  
Romantic Partners ◽  
Small Sample ◽  
Professional Care ◽  
Patient Disclosure ◽  
Previous Suicide Attempt

Abstract. Background: Patient disclosure of prior suicidal behaviors is critical for effectively managing suicide risk; however, many attempts go undisclosed. Aims: The current study explored how responses following a suicide attempt disclosure may relate to help-seeking outcomes. Method: Participants included 37 veterans with a previous suicide attempt receiving inpatient psychiatric treatment. Veterans reported on their most and least helpful experiences disclosing their suicide attempt to others. Results: Veterans disclosed their suicide attempt to approximately eight individuals. Mental health professionals were the most cited recipient of their most helpful disclosure; romantic partners were the most common recipient of their least helpful disclosures. Positive reactions within the context of the least helpful disclosure experience were positively associated with a sense of connection with the disclosure recipient. Positive reactions within the most helpful disclosure experience were positively associated with the likelihood of future disclosure. No reactions were associated with having sought professional care or likelihood of seeking professional care. Limitations: The results are considered preliminary due to the small sample size. Conclusion: Findings suggest that while positive reactions may influence suicide attempt disclosure experiences broadly, additional research is needed to clarify factors that drive the decision to disclose a suicide attempt to a professional.

Meeting Patients Where They Are

2017 ◽  
pp. 351-368
Author(s):  
Geri Lynn Baumblatt
Keyword(s):  
Decision Making ◽  
Health Literacy ◽  
Shared Decision Making ◽  
Decision Aid ◽  
Risk Information ◽  
Shared Decision ◽  
Low Health Literacy ◽  
Improved Outcomes ◽  
Aid Programs ◽  
Patient Disclosure

In this chapter the author describes the challenges of engaging and communicating with patients and how technology can improve communication, elicit honest patient disclosure, and create more productive conversation and help patients engage and partner in their care. The author will also discuss how research with multimedia programs reveals it can help reduce anxiety, improve knowledge, help low health literacy audiences, and contribute to improved outcomes. This chapter will also examine how multimedia decision aid programs can help patients understand their options and complex risk information, while helping them consider their values and preferences so they can truly engage in shared decision making.

scholarly journals The prevalence of patient disclosure of HIV infection to doctors.

1995 ◽  
Vol 85 (7) ◽  
pp. 1018-1019 ◽  
Author(s):  
G Marks ◽  
H R Mason ◽  
J M Simoni
Keyword(s):  
Hiv Infection ◽  
Patient Disclosure

“Doc, There's Something I Have To Tell You”: Patient Disclosure to Their Psychotherapist of Unprosecuted Murder and Other Violence

2010 ◽  
Vol 20 (5) ◽  
pp. 311-323 ◽  
Author(s):  
Steven Walfish ◽  
Jeffrey E. Barnett ◽  
Krista Marlyere ◽  
Robert Zielke
Keyword(s):  
Patient Disclosure

scholarly journals Perinatal Illicit Drug and Marijuana Use

2016 ◽  
Vol 31 (1) ◽  
pp. 35-42 ◽  
Author(s):  
Judy C. Chang ◽  
Cynthia L. Holland ◽  
Jill A. Tarr ◽  
Doris Rubio ◽  
Keri L. Rodriguez ◽  
...  
Keyword(s):  
Drug Use ◽  
Illicit Drugs ◽  
Illicit Drug ◽  
Obstetric Care ◽  
Illicit Drug Use ◽  
Urine Samples ◽  
Care Providers ◽  
Audio Recordings ◽  
Study Sites ◽  
Patient Disclosure

Purpose. To assess use, screening, and disclosure of perinatal marijuana and other illicit drugs during first obstetric visits. Design. Observational study that qualitatively assesses provider screening and patient disclosure of substance use. Setting. Study sites were five urban outpatient prenatal clinics and practices located in Pittsburgh, Pennsylvania. Participants. Pregnant patients and obstetric providers were recruited as participants. Methods. We audio recorded patient-provider conversations during first obstetric visits and obtained patient urine samples for drug analyses. Audio recordings were reviewed for provider screening and patient disclosure of illicit drug use. Urine analyses were compared with audio recordings to determine disclosure. Results. Four hundred and twenty-two pregnant patients provided complete audio recordings and urine samples for analyses. Providers asked about illicit drug use in 81% of the visits. One hundred twenty-three patients (29%) disclosed any current or past illicit drug use; 48 patients (11%) disclosed current use of marijuana while pregnant. One hundred and forty-five samples (34%) tested positive for one or more substances; marijuana was most commonly detected (N = 114, 27%). Of patients who tested positive for any substance, 66 (46%) did not disclose any use; only 36% of patients who tested positive for marijuana disclosed current use. Conclusion. Although marijuana is illegal in Pennsylvania, a high proportion of pregnant patients used marijuana, with many not disclosing use to their obstetric care providers.

scholarly journals Evaluation of a Revised Home Medication Experience Questionnaire (HOME-Qv2)

Pharmacy ◽  
2020 ◽  
Vol 8 (3) ◽  
pp. 169
Author(s):  
Matthew J. Witry ◽  
Olajide O. Fadare ◽  
Kassi Pham
Keyword(s):  
Pharmacist Intervention ◽  
Chronic Illnesses ◽  
Prescription Medications ◽  
Home Medication ◽  
Patient Medication ◽  
Patient Responses ◽  
Medication Experience ◽  
Patient Disclosure ◽  
Experience Questionnaire

The Home Medication Experience Questionnaire (HOME-Qv2) was developed to identify patient medication experience issues for pharmacist intervention. The study objectives were to (1) evaluate patient responses to the HOME-Qv2 medication experience questionnaire and (2) describe recommendations made by pharmacists in response to the identified medication experience issues and adoption of recommendations. The study sample was comprised of older adults, 55 years and above, who have one or more chronic illnesses for which they routinely take 4+ prescription medications. The HOME-Qv2 was administered to patients and a pharmacist made recommendations based on the responses. At 3 months, the research team followed up with participants via telephone, during which the HOME-Qv2 was again administered and participants shared their adoption of recommendations. Twenty-four patients completed the questionnaire, and twenty-one were available for follow-up. At 3 months, there was a significant decrease in patient self-reported HOME-Qv2 medication experience issues. There were 31 interventions/recommendations provided by the pharmacists, and 64.5% reported adopted. The HOME-Qv2 appears to facilitate patient disclosure of medication experience issues and informed targeted pharmacist recommendations.

Sign in / Sign up

Export Citation Format

Share Document